Genzyme Hits Sun With Suit Over Generic Leukemia Drug
Biotech company Genzyme Corp. on Thursday told a New Jersey federal court that Sun Pharmaceutical infringed on its patent for the injectable leukemia chemotherapy drug, Clolar, by applying to make and...To view the full article, register now.
Already a subscriber? Click here to view full article